KIR2DL3 Antibodies

Santa Cruz Biotechnology offers a broad range of KIR2DL3 monoclonal antibodies for immunology and cell biology research. KIR2DL3 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KIR2DL3, a member of the killer immunoglobulin-like receptor (KIR) family, plays a crucial role in the regulation of natural killer (NK) cell activity and the immune response. KIR2DL3 is involved in recognizing specific ligands on target cells, which is essential for maintaining immune tolerance and preventing autoimmunity. Understanding KIR2DL3 function has significant implications for cancer immunotherapy and transplant rejection research. Investigating KIR2DL3 expression patterns helps researchers uncover new insights into NK cell biology and immune system regulation. Studying KIR2DL3 interactions with target cells advances our understanding of immune response mechanisms. Exploring KIR2DL3 signaling pathways contributes to the development of novel therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of immune system regulation and potential therapeutic applications.